Clinical Trials
12 trialsNCT05615376 2025-04-01
Beat to Beat A Study in Paediatric, Adolescent and Young Adult Patients Who Are Undergoing or Have Undergone Cancer Therapy to Evaluate the Agreement Between QTc Measured Using 12 Lead Electrocardiogram (ECG) and a Wearable Device ECG
Murdoch Childrens Research Institute
Phase NA Completed
NCT03098589 2025-03-30
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Celgene
Completed
NCT01431326 2023-09-06
PTN_POPS
Duke University
Completed
NCT01370278 2023-08-25
Clearance Of Mucus In Stents (COMIS)
M.D. Anderson Cancer Center
Phase NA Completed
NCT05226416 2023-05-09
ACTIV4
Eurasian Association of Therapists
Completed
NCT02921828 2022-07-05
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Celgene
Completed
NCT02921802 2022-06-14
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Celgene
Completed
NCT02922543 2022-06-14
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Celgene
Completed
NCT02668250 2021-08-26
OPTI-AGED
Centre Hospitalier Universitaire de Saint Etienne
Phase NA Completed
NCT03243604 2018-10-18
ARBITRAGE
Groupe Hospitalier Pitie-Salpetriere
Completed
NCT02988219 2017-05-30
Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method
Medical University of Warsaw
Phase 4 Completed
NCT00575523 2008-01-25
atropinePEI
Medical University of Vienna
Phase 4 Completed